Combination Treatment of S-1 With Paclitaxel Versus Paclitaxel+Cisplatin and 5-Fu+Cisplatin as First-line Treatment in Advanced Esophageal Cancer
Phase of Trial: Phase II/III
Latest Information Update: 10 Apr 2017
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary) ; Cisplatin; Fluorouracil; Paclitaxel
- Indications Oesophageal cancer
- Focus Therapeutic Use
- 05 Apr 2017 Status changed from recruiting to discontinued.
- 29 Mar 2016 Planned primary completion date changed from 1 Jul 2013 to 1 Dec 2017, according to ClinicalTrials.gov record.
- 28 Mar 2016 Planned End Date changed from 1 Jul 2013 to 1 Dec 2017, according to ClinicalTrials.gov record.